Adaptimmune’s pivotal Phase II trial of its investigational T cell therapy lete-cel has met its primary endpoint ...
Neutrophil-to-lymphocyte ratio (NLR) is a significant prognostic indicator in myeloproliferative neoplasms, correlating with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback